Assessing acute effects of methylphenidate and modafinil on inhibitory capacity, time estimation, attentional lapses, and compulsive-like behavior in rats

Medications known as 'cognitive enhancers' are increasingly being consumed off-label by healthy people, raising concerns about their safety. The aim of our study was to profile behavioral performance upon oral administration of methylphenidate (2.5 mg/kg) and modafinil (64 mg/kg) - two pop...

Full description

Saved in:
Bibliographic Details
Published inBehavioural pharmacology Vol. 36; no. 2-3; p. 76
Main Authors Sosa, Rodrigo, Espinosa-Villafranca, Pedro, Saavedra, Pablo, Chávez-Hernández, María Elena, Leal-Galicia, Perla, Lago, Gustavo, Mata, Florencia, Mata-Luévanos, Jesús, Rodríguez-Serrano, Luis Miguel, Tapia-De-Jesús, Alejandro, Buenrostro-Jáuregui, Mario
Format Journal Article
LanguageEnglish
Published England 01.04.2025
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Medications known as 'cognitive enhancers' are increasingly being consumed off-label by healthy people, raising concerns about their safety. The aim of our study was to profile behavioral performance upon oral administration of methylphenidate (2.5 mg/kg) and modafinil (64 mg/kg) - two popular cognitive enhancers - and upon their discontinuation. We modeled cognitively demanding challenges in neurotypical individuals using a behavioral task where Wistar - Lewis rats had to withhold responses for a specified time to obtain food rewards. This task allowed us to extract several measures of behavioral performance associated with clinically meaningful indices, such as compulsive-like responding, incapacity to wait (impulsivity), time estimation (precision and accuracy), and attentional lapses. Our study design involved examining these behavioral indices in subjects administered either methylphenidate, modafinil, or vehicle. We found that subjects administered modafinil obtained fewer rewards and were less efficient in reward pursuing than the vehicle group; this result was likely due to a drug-induced inability to wait. Upon modafinil discontinuation, subjects earned more rewards but did not entirely catch up with the vehicle group. As for methylphenidate, neither favorable nor unfavorable effects were found in our main analyses. However, an exploratory analysis of changes in behavioral performance within sessions suggested that methylphenidate fostered favorable, yet short-lived, effects. We discuss our results in terms of the risks and cost-benefits of doses above or below the effective dose of cognitive enhancement drugs.
ISSN:1473-5849
DOI:10.1097/FBP.0000000000000815